Substance active (DCI)
- paclitaxel (dans une formulation de nanoparticules liées à l’albumine)
Informations techniques
Présentation
PAZENIR 5 mg/mL, poudre pour dispersion pour perfusion
1 flacon en verre de 100 mg (CIP : 34009 301 845 9 2)
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
3RVRVeC5ZfT6nSdq